Nicola Campbell
Nicola Campbell is a general partner at Sofinnova Ventures. She joined Sofinnova in 2004 to focus on early-stage investment opportunities in the sectors of drug discovery and pharmaceutical & biologic development.
Previously, Nicola worked for BA Venture Partners, Burrill & Company and Genentech. Nicola received her Ph.D. in Molecular and Cellular Immunology from Mount Sinai Medical Center.
Recent Posts
The silver lining to the biotech IPO cloud
(Editor’s note: At VentureBeat, we’ve been pretty caught up with Web 2.0 lately — where there is acquisition fever. But take a look at biotech. Nicola Campbell has been one of the more active venture capitalists in the biotech industry over the past year, leading investments in Alvine, Marinus and Nextwave. Note her conclusion. Sound familiar?)
In the recent past, biotech was hot, IPOs were robust, and companies in their earliest trials were the hope of… Continue Reading